Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

Lancet

Volumn 352, Issue 9122, 1998, Pages 98-101

  Powles, Trevor ^a   Eeles, Ros ^b   Ashley, Sue ^a   Easton, Doug ^c   Chang, Jenny ^a   Dowsett, Mitch ^a   Tidy, Alwynne ^a   Viggers, Jenny ^a   Davey, Jane ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; ESTROGEN THERAPY; FAMILIAL CANCER; FEMALE; GYNECOLOGY; HEADACHE; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL IRREGULARITY; MOOD; NAUSEA; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

EID: 0032508294     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)85012-5     Document Type: Article

References (18)

1. Jordan V. Effect of tamoxifen (ICI 46, 474) on initiation and growth of DMBA-induced rat mammary carcinomata. Eur J Cancer 1976; 12: 419-25.
2. Nolvadex Adjuvant Trial Organisation. Controlled trial of tamoxifen as adjuvant agent in management of early breast cancer; interim analysis at four years by Nolvadex Adjuvant Trial Organisation. Lancet 1983; i: 257-61.
3. Early Breast Cancer Trialists' Collaborative Group. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. N Engl J Med 1988; 319: 1681-92.
4. Cuzick J, Baum M. Tamoxifen and contralateral breast cancer. Lancet 1985; ii: 282.
5. Powles T, Hardy J, Ashley S, et al. A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer. Br J Cancer 1989; 60: 126-31.
6. Love R, Mazess R, Barden H, et al. Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med 1992; 326: 852-56.
7. Johnston S, Haynes B, Sucks N, et al. Effect of oestrogen receptor status and time on the intra-tumoural accumulation of tamoxifen and N-desmethyltamoxifen following short-term therapy in human primary breast cancer. Breast Cancer Res Treat 1993; 28: 241-50.
8. Cohn J, McNamara J, Schaefer E. Lipoprotein and cholesterol concentradons in the plasma of human subjects as measured in the food and fasting status. Clin Chem 1988; 34: 2456-59.
9. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 1998; 351: 1451-67.
10. Stat Bite. Breast cancer incidence in the breast cancer prevention trial. J Natl Cancer Inst 1998; 90: 648.
11. Powles TJ, Hickish T, Kanis JA, Tidy A, Ashley S. Effect of tamoxifen on bone mineral density measured by dual-energy X-ray absorptiometry in healthy premenopausal and postmenopausal women. J Clin Oncol 1996; 14: 78-84.
12. Powles T, Bourne T, Athanasiou S, et al. The effects of norethisterone on endometrial abnormalities identified by transvaginal ultrasound screening of healthy postmenopausal women on tamoxifen or placebo. Br J Cancer (in press).
13. Claus E, Risch M, Thompson W. Age at onset as at: indicator of familial risk of breast cancer. Am J Epidemiol 1990; 131: 961-72.
14. Osin P, Crook T, Powles T, Gusterson B. Hormone status of in-situ cancer in BRCA1 and BRCA2 mutation carriers. Lancet 1998; 351: 1487.
15. Jordan V, Lababidi M, Langan-Fahey S. Suppression of mouse mammary tumorigenesis by long-term tamoxifen therapy. J Natl Cancer Inst 1991; 83: 492-96.
16. Rutqvist L, Johansson H, Signomklao T, Johansson U, Fornander T, Wilking N. Adjuvant tamoxifen therapy for early staye breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group. J Natl Cancer Inst 1995; 87: 645-51.
17. Powles TJ, Hickish T. Tamoxifen therapy and carcinogenic risk. J Natl Cancer Inst 1995; 87: 1343-44.
18. Scully R, Chen J, Plug A, et al. Association of the BRCA1 gene product with Rad51 in meiotic and mitotic cells. Cell 1997; 88: 265-75.